Structural insights into the enzymatic mechanism of the pathogenic MAPK phosphothreonine lyase
about
Discovery of unique lanthionine synthetases reveals new mechanistic and evolutionary insightsShigella flexneri type III secretion system effectors OspB and OspF target the nucleus to downregulate the host inflammatory response via interactions with retinoblastoma proteinKilling two birds with one stone: trans-kingdom suppression of PAMP/MAMP-induced immunity by T3E from enteropathogenic bacteriaComplex structure of OspI and Ubc13: the molecular basis of Ubc13 deamidation and convergence of bacterial and host E2 recognitionAn image classification approach to analyze the suppression of plant immunity by the human pathogen Salmonella Typhimurium.SpvC is a Salmonella effector with phosphothreonine lyase activity on host mitogen-activated protein kinasesBacteria fighting back: how pathogens target and subvert the host innate immune system.Genome-wide search for eliminylating domains reveals novel function for BLES03-like proteins.Tipping the balance by manipulating post-translational modifications.Streptocollin, a Type IV Lanthipeptide Produced by Streptomyces collinus Tü 365.Molecular mechanism for eliminylation, a newly discovered post-translational modificationAlterations of host cell ubiquitination machinery by pathogenic bacteria.Engineering Escherichia coli into a protein delivery system for mammalian cells.Inhibition of Nuclear Transport of NF-ĸB p65 by the Salmonella Type III Secretion System Effector SpvD.Consistent activation of the β-catenin pathway by Salmonella type-three secretion effector protein AvrA in chronically infected intestine.Structural basis of rifampin inactivation by rifampin phosphotransferase.Systems-level overview of host protein phosphorylation during Shigella flexneri infection revealed by phosphoproteomics.The Campylobacter jejuni CiaD effector protein activates MAP kinase signaling pathways and is required for the development of disease.Active-site dynamics of SpvC virulence factor from Salmonella typhimurium and density functional theory study of phosphothreonine lyase catalysis.Potential of known and short prokaryotic protein motifs as a basis for novel peptide-based antibacterial therapeutics: a computational survey.The Salmonella Effector SpvD Is a Cysteine Hydrolase with a Serovar-specific Polymorphism Influencing Catalytic Activity, Suppression of Immune Responses, and Bacterial Virulence.Pathogenic Bacterial Proteins and their Anti-Inflammatory Effects in the Eukaryotic Host.Proteomics as a probe of microbial pathogenesis and its molecular boundaries.A genetically encoded multifunctional unnatural amino acid for versatile protein manipulations in living cells.Post-translational modifications in host cells during bacterial infection.Functional domains and motifs of bacterial type III effector proteins and their roles in infection.The streptomycin mouse model for Salmonella diarrhea: functional analysis of the microbiota, the pathogen's virulence factors, and the host's mucosal immune response.The current Salmonella-host interactome.Lost after translation: post-translational modifications by bacterial type III effectors.'Drugs from bugs': bacterial effector proteins as promising biological (immune-) therapeutics.Structural insight into effector proteins of Gram-negative bacterial pathogens that modulate the phosphoproteome of their host.Mechanistic Understanding of Lanthipeptide Biosynthetic Enzymes.How Do the Virulence Factors of Shigella Work Together to Cause Disease?Effects of Coxiella burnetii on MAPKinases phosphorylation.Bacterial virulence proteins as tools to rewire kinase pathways in yeast and immune cells.Mechanistic studies of Ser/Thr dehydration catalyzed by a member of the LanL lanthionine synthetase familyKlebsiella pneumoniae NdpA suppresses ERK pathway-mediated host early inflammatory responses and is degraded through the ubiquitin-proteasome pathway.How to rewire the host cell: A home improvement guide for intracellular bacteria.The eukaryotic linear motif resource - 2018 update.Salmonella type III effector SpvC, a phosphothreonine lyase, contributes to reduction in inflammatory response during intestinal phase of infection.
P2860
Q21145797-38237331-5E13-417B-94E0-494A757782DBQ24315859-62B10FCD-9650-45C5-94A0-81A349D2A21EQ26822456-9BC7ED26-B8DF-4152-B6F4-7418ACCC281DQ28486903-AC6CA060-53A5-4853-ACF7-4ABF37A135E0Q30529664-49B52F09-288F-49DE-9AA7-3E69E9256299Q33320330-6804D156-CB5C-43E8-8F37-0ABC9C8E8FEEQ33623288-9928B00C-A51C-44A8-AC10-6F32AD3F4EDDQ34154723-E5A39E50-B306-4617-B349-9069E301072AQ34477679-9BF368E6-712D-4D9F-A27E-7A67855614CFQ34496842-F55FCE0D-13D1-4B36-89DD-E1BEE6CAA432Q35119053-CF297813-E2F4-4058-9537-C3A20558C915Q35129187-72346B30-2492-4E6F-B9C8-6972005492E3Q35597577-2D7D03B0-8AF7-4A2D-9D5F-C4656DD231BCQ36032316-3B15F154-426A-40F4-8551-483669E40647Q36454282-7C6A0E0D-FE7F-4E28-9587-6207793985D6Q36802479-3C3FF629-6725-4D2A-A62B-BF1921FBCEBCQ37214709-6E6E7E17-A5C3-456F-A9A5-3EBBB770600FQ37323304-77098C7E-1F5A-4DDD-8383-7817BEC7BAECQ37438776-27D31385-7F7B-4F06-A892-F3F13F9980B5Q37498015-B0AB9D73-F592-4CA2-9FB5-864ADF70D143Q37551274-D8904E75-9370-4E0F-A4A8-4665ADB3DAE6Q37678929-2CE097FD-2397-4DA2-9F3C-D6F8A13B2FCBQ37689718-45F76220-50CD-44E8-9D93-6FC54BB9D442Q37707852-4350B94F-7ACF-45E4-9363-D2102EB29A4EQ37759341-CBD13097-7B51-4915-9A79-B4CD629CE6FFQ37850977-31029CF3-9A2A-40DD-8096-C57D6142984AQ37968294-E351BED6-54F6-4D69-8559-97BBF2C27B74Q37972868-29F5178E-FF4D-4C7A-ADDD-36618F49B378Q38087113-24E62581-260F-4458-97DC-01608055BE7BQ38164827-D28E6B10-64FA-46DB-8B6F-6BBA50609354Q38309987-CD2ED7C8-0FCB-4565-A9EC-33213C79A35AQ39109460-C308304C-0E00-4CDC-AC09-79D5721EF594Q39230762-DE5FF545-24B2-4AA8-834F-707126863176Q40305605-1F56E80B-0857-4796-AC52-EE26019C17A6Q41411382-0BEBEAFC-751B-480A-88FF-D36B82E321CFQ42113226-C458A250-7869-4113-BEEF-6E65704807E2Q42324112-23AEC876-1FDD-41FC-9319-279945670A0AQ46552034-B12C74D8-FDF7-442A-8647-6AE386E2BF60Q47159538-A92DB920-7BF2-4396-A7C8-0DF0EEBEB9F0Q50033878-2E8021F1-DDE9-4099-A4FA-D33ABD7706F4
P2860
Structural insights into the enzymatic mechanism of the pathogenic MAPK phosphothreonine lyase
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Structural insights into the e ...... ic MAPK phosphothreonine lyase
@ast
Structural insights into the e ...... ic MAPK phosphothreonine lyase
@en
Structural insights into the e ...... ic MAPK phosphothreonine lyase
@nl
type
label
Structural insights into the e ...... ic MAPK phosphothreonine lyase
@ast
Structural insights into the e ...... ic MAPK phosphothreonine lyase
@en
Structural insights into the e ...... ic MAPK phosphothreonine lyase
@nl
prefLabel
Structural insights into the e ...... ic MAPK phosphothreonine lyase
@ast
Structural insights into the e ...... ic MAPK phosphothreonine lyase
@en
Structural insights into the e ...... ic MAPK phosphothreonine lyase
@nl
P2093
P3181
P1433
P1476
Structural insights into the e ...... ic MAPK phosphothreonine lyase
@en
P2093
Chengzu Long
Da-Cheng Wang
Hongtao Li
Liping Liu
Yongqun Zhu
P304
P3181
P356
10.1016/J.MOLCEL.2007.11.011
P577
2007-12-14T00:00:00Z